1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Tablets 1.2.3 Pills 1.2.4 Oral Liquid 1.3 Market by Application 1.3.1 Global Pediatric Gastrointestinal Drugs Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.3.4 Retail Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pediatric Gastrointestinal Drugs Market Perspective (2017-2028) 2.2 Pediatric Gastrointestinal Drugs Growth Trends by Region 2.2.1 Pediatric Gastrointestinal Drugs Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Pediatric Gastrointestinal Drugs Historic Market Size by Region (2017-2022) 2.2.3 Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2023-2028) 2.3 Pediatric Gastrointestinal Drugs Market Dynamics 2.3.1 Pediatric Gastrointestinal Drugs Industry Trends 2.3.2 Pediatric Gastrointestinal Drugs Market Drivers 2.3.3 Pediatric Gastrointestinal Drugs Market Challenges 2.3.4 Pediatric Gastrointestinal Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue 3.1.1 Global Top Pediatric Gastrointestinal Drugs Players by Revenue (2017-2022) 3.1.2 Global Pediatric Gastrointestinal Drugs Revenue Market Share by Players (2017-2022) 3.2 Global Pediatric Gastrointestinal Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Pediatric Gastrointestinal Drugs Revenue 3.4 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio 3.4.1 Global Pediatric Gastrointestinal Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pediatric Gastrointestinal Drugs Revenue in 2021 3.5 Pediatric Gastrointestinal Drugs Key Players Head office and Area Served 3.6 Key Players Pediatric Gastrointestinal Drugs Product Solution and Service 3.7 Date of Enter into Pediatric Gastrointestinal Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pediatric Gastrointestinal Drugs Breakdown Data by Type 4.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Type (2017-2022) 4.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2023-2028) 5 Pediatric Gastrointestinal Drugs Breakdown Data by Application 5.1 Global Pediatric Gastrointestinal Drugs Historic Market Size by Application (2017-2022) 5.2 Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Pediatric Gastrointestinal Drugs Market Size (2017-2028) 6.2 North America Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) 6.3 North America Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Pediatric Gastrointestinal Drugs Market Size (2017-2028) 7.2 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) 7.3 Europe Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size (2017-2028) 8.2 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) 8.3 Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Pediatric Gastrointestinal Drugs Market Size (2017-2028) 9.2 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) 9.3 Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size (2017-2028) 10.2 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) 10.3 Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 AstraZeneca 11.1.1 AstraZeneca Company Detail 11.1.2 AstraZeneca Business Overview 11.1.3 AstraZeneca Pediatric Gastrointestinal Drugs Introduction 11.1.4 AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.1.5 AstraZeneca Recent Development 11.2 Sanofi 11.2.1 Sanofi Company Detail 11.2.2 Sanofi Business Overview 11.2.3 Sanofi Pediatric Gastrointestinal Drugs Introduction 11.2.4 Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.2.5 Sanofi Recent Development 11.3 Aptalis 11.3.1 Aptalis Company Detail 11.3.2 Aptalis Business Overview 11.3.3 Aptalis Pediatric Gastrointestinal Drugs Introduction 11.3.4 Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.3.5 Aptalis Recent Development 11.4 Eisai 11.4.1 Eisai Company Detail 11.4.2 Eisai Business Overview 11.4.3 Eisai Pediatric Gastrointestinal Drugs Introduction 11.4.4 Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.4.5 Eisai Recent Development 11.5 Pfizer 11.5.1 Pfizer Company Detail 11.5.2 Pfizer Business Overview 11.5.3 Pfizer Pediatric Gastrointestinal Drugs Introduction 11.5.4 Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.5.5 Pfizer Recent Development 11.6 Zeria (Tillotts) 11.6.1 Zeria (Tillotts) Company Detail 11.6.2 Zeria (Tillotts) Business Overview 11.6.3 Zeria (Tillotts) Pediatric Gastrointestinal Drugs Introduction 11.6.4 Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.6.5 Zeria (Tillotts) Recent Development 11.7 GlaxoSmithKline 11.7.1 GlaxoSmithKline Company Detail 11.7.2 GlaxoSmithKline Business Overview 11.7.3 GlaxoSmithKline Pediatric Gastrointestinal Drugs Introduction 11.7.4 GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.7.5 GlaxoSmithKline Recent Development 11.8 Salix Pharmaceuticals 11.8.1 Salix Pharmaceuticals Company Detail 11.8.2 Salix Pharmaceuticals Business Overview 11.8.3 Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Introduction 11.8.4 Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.8.5 Salix Pharmaceuticals Recent Development 11.9 Perrigo 11.9.1 Perrigo Company Detail 11.9.2 Perrigo Business Overview 11.9.3 Perrigo Pediatric Gastrointestinal Drugs Introduction 11.9.4 Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.9.5 Perrigo Recent Development 11.10 Abbott 11.10.1 Abbott Company Detail 11.10.2 Abbott Business Overview 11.10.3 Abbott Pediatric Gastrointestinal Drugs Introduction 11.10.4 Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.10.5 Abbott Recent Development 11.11 Honz Pharmaceutical 11.11.1 Honz Pharmaceutical Company Detail 11.11.2 Honz Pharmaceutical Business Overview 11.11.3 Honz Pharmaceutical Pediatric Gastrointestinal Drugs Introduction 11.11.4 Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.11.5 Honz Pharmaceutical Recent Development 11.12 Shandong DYNE Marine Biopharmaceutical 11.12.1 Shandong DYNE Marine Biopharmaceutical Company Detail 11.12.2 Shandong DYNE Marine Biopharmaceutical Business Overview 11.12.3 Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal Drugs Introduction 11.12.4 Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.12.5 Shandong DYNE Marine Biopharmaceutical Recent Development 11.13 Sunflower Pharmaceutical 11.13.1 Sunflower Pharmaceutical Company Detail 11.13.2 Sunflower Pharmaceutical Business Overview 11.13.3 Sunflower Pharmaceutical Pediatric Gastrointestinal Drugs Introduction 11.13.4 Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.13.5 Sunflower Pharmaceutical Recent Development 11.14 Jiangzhong Pharmaceutical 11.14.1 Jiangzhong Pharmaceutical Company Detail 11.14.2 Jiangzhong Pharmaceutical Business Overview 11.14.3 Jiangzhong Pharmaceutical Pediatric Gastrointestinal Drugs Introduction 11.14.4 Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.14.5 Jiangzhong Pharmaceutical Recent Development 11.15 Yabao Pharmaceutical 11.15.1 Yabao Pharmaceutical Company Detail 11.15.2 Yabao Pharmaceutical Business Overview 11.15.3 Yabao Pharmaceutical Pediatric Gastrointestinal Drugs Introduction 11.15.4 Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.15.5 Yabao Pharmaceutical Recent Development 11.16 Jumpcan Pharmaceutical 11.16.1 Jumpcan Pharmaceutical Company Detail 11.16.2 Jumpcan Pharmaceutical Business Overview 11.16.3 Jumpcan Pharmaceutical Pediatric Gastrointestinal Drugs Introduction 11.16.4 Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.16.5 Jumpcan Pharmaceutical Recent Development 11.17 Hansen Pharmaceutical 11.17.1 Hansen Pharmaceutical Company Detail 11.17.2 Hansen Pharmaceutical Business Overview 11.17.3 Hansen Pharmaceutical Pediatric Gastrointestinal Drugs Introduction 11.17.4 Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) 11.17.5 Hansen Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pediatric Gastrointestinal Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Tablets Table 3. Key Players of Pills Table 4. Key Players of Oral Liquid Table 5. Global Pediatric Gastrointestinal Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Pediatric Gastrointestinal Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Pediatric Gastrointestinal Drugs Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Pediatric Gastrointestinal Drugs Market Share by Region (2017-2022) Table 9. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Pediatric Gastrointestinal Drugs Market Share by Region (2023-2028) Table 11. Pediatric Gastrointestinal Drugs Market Trends Table 12. Pediatric Gastrointestinal Drugs Market Drivers Table 13. Pediatric Gastrointestinal Drugs Market Challenges Table 14. Pediatric Gastrointestinal Drugs Market Restraints Table 15. Global Pediatric Gastrointestinal Drugs Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Pediatric Gastrointestinal Drugs Market Share by Players (2017-2022) Table 17. Global Top Pediatric Gastrointestinal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2021) Table 18. Ranking of Global Top Pediatric Gastrointestinal Drugs Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Pediatric Gastrointestinal Drugs Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Pediatric Gastrointestinal Drugs Product Solution and Service Table 22. Date of Enter into Pediatric Gastrointestinal Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Pediatric Gastrointestinal Drugs Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2017-2022) Table 26. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Type (2023-2028) Table 28. Global Pediatric Gastrointestinal Drugs Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Application (2017-2022) Table 30. Global Pediatric Gastrointestinal Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Pediatric Gastrointestinal Drugs Revenue Market Share by Application (2023-2028) Table 32. North America Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size by Country (2023-2028) & (US$ Million) Table 42. AstraZeneca Company Detail Table 43. AstraZeneca Business Overview Table 44. AstraZeneca Pediatric Gastrointestinal Drugs Product Table 45. AstraZeneca Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 46. AstraZeneca Recent Development Table 47. Sanofi Company Detail Table 48. Sanofi Business Overview Table 49. Sanofi Pediatric Gastrointestinal Drugs Product Table 50. Sanofi Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 51. Sanofi Recent Development Table 52. Aptalis Company Detail Table 53. Aptalis Business Overview Table 54. Aptalis Pediatric Gastrointestinal Drugs Product Table 55. Aptalis Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 56. Aptalis Recent Development Table 57. Eisai Company Detail Table 58. Eisai Business Overview Table 59. Eisai Pediatric Gastrointestinal Drugs Product Table 60. Eisai Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 61. Eisai Recent Development Table 62. Pfizer Company Detail Table 63. Pfizer Business Overview Table 64. Pfizer Pediatric Gastrointestinal Drugs Product Table 65. Pfizer Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 66. Pfizer Recent Development Table 67. Zeria (Tillotts) Company Detail Table 68. Zeria (Tillotts) Business Overview Table 69. Zeria (Tillotts) Pediatric Gastrointestinal Drugs Product Table 70. Zeria (Tillotts) Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 71. Zeria (Tillotts) Recent Development Table 72. GlaxoSmithKline Company Detail Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Pediatric Gastrointestinal Drugs Product Table 75. GlaxoSmithKline Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 76. GlaxoSmithKline Recent Development Table 77. Salix Pharmaceuticals Company Detail Table 78. Salix Pharmaceuticals Business Overview Table 79. Salix Pharmaceuticals Pediatric Gastrointestinal Drugs Product Table 80. Salix Pharmaceuticals Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 81. Salix Pharmaceuticals Recent Development Table 82. Perrigo Company Detail Table 83. Perrigo Business Overview Table 84. Perrigo Pediatric Gastrointestinal Drugs Product Table 85. Perrigo Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 86. Perrigo Recent Development Table 87. Abbott Company Detail Table 88. Abbott Business Overview Table 89. Abbott Pediatric Gastrointestinal Drugs Product Table 90. Abbott Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 91. Abbott Recent Development Table 92. Honz Pharmaceutical Company Detail Table 93. Honz Pharmaceutical Business Overview Table 94. Honz Pharmaceutical Pediatric Gastrointestinal DrugsProduct Table 95. Honz Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 96. Honz Pharmaceutical Recent Development Table 97. Shandong DYNE Marine Biopharmaceutical Company Detail Table 98. Shandong DYNE Marine Biopharmaceutical Business Overview Table 99. Shandong DYNE Marine Biopharmaceutical Pediatric Gastrointestinal DrugsProduct Table 100. Shandong DYNE Marine Biopharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 101. Shandong DYNE Marine Biopharmaceutical Recent Development Table 102. Sunflower Pharmaceutical Company Detail Table 103. Sunflower Pharmaceutical Business Overview Table 104. Sunflower Pharmaceutical Pediatric Gastrointestinal DrugsProduct Table 105. Sunflower Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 106. Sunflower Pharmaceutical Recent Development Table 107. Jiangzhong Pharmaceutical Company Detail Table 108. Jiangzhong Pharmaceutical Business Overview Table 109. Jiangzhong Pharmaceutical Pediatric Gastrointestinal DrugsProduct Table 110. Jiangzhong Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 111. Jiangzhong Pharmaceutical Recent Development Table 112. Yabao Pharmaceutical Company Detail Table 113. Yabao Pharmaceutical Business Overview Table 114. Yabao Pharmaceutical Pediatric Gastrointestinal DrugsProduct Table 115. Yabao Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 116. Yabao Pharmaceutical Recent Development Table 117. Jumpcan Pharmaceutical Company Detail Table 118. Jumpcan Pharmaceutical Business Overview Table 119. Jumpcan Pharmaceutical Pediatric Gastrointestinal DrugsProduct Table 120. Jumpcan Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 121. Jumpcan Pharmaceutical Recent Development Table 122. Hansen Pharmaceutical Company Detail Table 123. Hansen Pharmaceutical Business Overview Table 124. Hansen Pharmaceutical Pediatric Gastrointestinal DrugsProduct Table 125. Hansen Pharmaceutical Revenue in Pediatric Gastrointestinal Drugs Business (2017-2022) & (US$ Million) Table 126. Hansen Pharmaceutical Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Pediatric Gastrointestinal Drugs Market Share by Type: 2021 VS 2028 Figure 2. Tablets Features Figure 3. Pills Features Figure 4. Oral Liquid Features Figure 5. Global Pediatric Gastrointestinal Drugs Market Share by Application in 2021 & 2028 Figure 6. Hospital Pharmacies Case Studies Figure 7. Online Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Pediatric Gastrointestinal Drugs Report Years Considered Figure 10. Global Pediatric Gastrointestinal Drugs Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Pediatric Gastrointestinal Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Pediatric Gastrointestinal Drugs Market Share by Region: 2021 VS 2028 Figure 13. Global Pediatric Gastrointestinal Drugs Market Share by Players in 2021 Figure 14. Global Top Pediatric Gastrointestinal Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Gastrointestinal Drugs as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Pediatric Gastrointestinal Drugs Revenue in 2021 Figure 16. North America Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Pediatric Gastrointestinal Drugs Market Share by Country (2017-2028) Figure 18. United States Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Pediatric Gastrointestinal Drugs Market Share by Country (2017-2028) Figure 22. Germany Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Pediatric Gastrointestinal Drugs Market Share by Region (2017-2028) Figure 30. China Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Pediatric Gastrointestinal Drugs Market Share by Country (2017-2028) Figure 38. Mexico Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Pediatric Gastrointestinal Drugs Market Share by Country (2017-2028) Figure 42. Turkey Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Pediatric Gastrointestinal Drugs Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. AstraZeneca Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 45. Sanofi Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 46. Aptalis Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 47. Eisai Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 48. Pfizer Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 49. Zeria (Tillotts) Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 50. GlaxoSmithKline Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 51. Salix Pharmaceuticals Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 52. Perrigo Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 53. Abbott Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 54. Honz Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 55. Shandong DYNE Marine Biopharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 56. Sunflower Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 57. Jiangzhong Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 58. Yabao Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 59. Jumpcan Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 60. Hansen Pharmaceutical Revenue Growth Rate in Pediatric Gastrointestinal Drugs Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

AstraZeneca Sanofi Aptalis Eisai Pfizer Zeria (Tillotts) GlaxoSmithKline Salix Pharmaceuticals Perrigo Abbott Honz Pharmaceutical Shandong DYNE Marine Biopharmaceutical Sunflower Pharmaceutical Jiangzhong Pharmaceutical Yabao Pharmaceutical Jumpcan Pharmaceutical Hansen Pharmaceutical